FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing compound I (ivosidenib) used in treating patients with haematological malignancies. Disclosed method involves extraction of crystalline ethanol solvate of compound IIa and conversion of ethanol solvate of compound IIa to compound I or its solvate. Invention also relates to a crystalline ethanol solvate of compound IIa and a method for production thereof.
EFFECT: disclosed method enables efficient synthesis of ivosidenib using diastereomerically pure crystalline ethanol solvate of compound IIa.
29 cl, 2 dwg, 4 tbl, 46 ex
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLINE MODIFICATION | 2014 |
|
RU2666368C2 |
CRYSTALLINE FORMS OF 1-(ACYLOXY)-ALKYLCARBAMATE CONJUGATES OF NAPROXEN AND PREGABALIN | 2019 |
|
RU2799809C2 |
VINORELBINE MONOTARTRATE AND ITS PHARMACEUTICAL APPLICATION | 2016 |
|
RU2730521C2 |
IMIDAZOLONYLQUINOLINE COMPOUNDS AND THERAPEUTIC USE THEREOF | 2020 |
|
RU2822479C2 |
ESSENTIALLY CRYSTALLINE MELAGATRAN FORM | 2000 |
|
RU2243973C2 |
METHOD OF NEBIVOLOL RACEMATE OBTAINMENT | 2006 |
|
RU2392277C2 |
ANHYDROUS CRYSTALLINE AZIDOCYTOSINE HEMISULPHATE | 2003 |
|
RU2334756C2 |
INHIBITORS OF AMIDE-HYDROLASE OF FATTY ACIDS | 2011 |
|
RU2569061C2 |
POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF PHARMACEUTICAL COMPOUND | 2010 |
|
RU2575173C2 |
AMINE SOLVATE OF SODIUM GLUCOSE OPENER OF SODIUM GLUCOSE OPENER AND METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2710230C1 |
Authors
Dates
2024-08-06—Published
2020-08-07—Filed